Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Meningeal Neoplasms × eribulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 HR Positive HER2 Negative Advanced Breast Cancer 1 HER2-negative Breast Cancer 1 Breast Neoplasms, Male 1 Breast Cancer Organoids 1 Brain Neoplasms 1

Interventions

paclitaxel-Angiopep-2 conjugate 1 eribulin 1 Methotrexate 1 Capecitabine 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡